Clinical significance of macroscopic T-wave alternans after sodium channel blocker administration in patients with Brugada syndrome.
about
Brugada Syndrome:Risk Stratification And ManagementRisk stratification in electrical cardiomyopathies.[Brugada ECG].Microvolt T-wave alternans physiological basis, methods of measurement, and clinical utility--consensus guideline by International Society for Holter and Noninvasive Electrocardiology.J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledgeBrugada syndrome: recent advances and controversies.Basis for sudden cardiac death prediction by T-wave alternans from an integrative physiology perspectiveExplaining the clinical manifestations of T wave alternans in patients at risk for sudden cardiac deathArrhythmic risk biomarkers for the assessment of drug cardiotoxicity: from experiments to computer simulations.T-wave alternans and arrhythmogenesis in cardiac diseases.New electrocardiographic features in Brugada syndrome.The clinical value of T-wave alternans derived from Holter monitoring.The pathophysiological mechanism underlying Brugada syndrome: depolarization versus repolarizationIncreased right ventricular repolarization gradients promote arrhythmogenesis in a murine model of Brugada syndrome.J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge.High risk electrocardiographic markers in Brugada syndrome.Prognostic Significance of the Sodium Channel Blocker Test in Patients With Brugada Syndrome.
P2860
Q28078338-CAFD5C68-BA03-4F62-942B-5D85E6B44DC6Q33158278-BE792CC4-7AD3-47DB-B55A-2B987AA4811EQ33166094-9A604D43-D768-41D7-B99D-541F6099BCB4Q33952439-30762270-5770-4088-A507-2263DAC8149CQ34534329-C4E94FB2-49C3-4EA0-9010-A8E2DF9B5531Q37037890-CB5AA56C-B993-4C34-8EB3-D958B1760933Q37167055-768ADB61-3897-48F3-9DA4-006FB4DEBF7CQ37377073-3D8172A2-C713-45C4-9747-E3240ABFF9CEQ37755876-CF991355-5011-4EA6-896E-003BE600B036Q37834308-B361967C-C2B3-46C0-B4A7-8A7016092C37Q38211723-B5414832-2317-4E23-B589-A46F35DC2D4CQ39198845-AD107EBD-E301-428E-A88A-C14320CE0AAAQ41772555-29D21E38-16BA-4B8A-810A-6258237B614AQ42026470-9C033F44-BCDA-4BDF-8959-2E7C085BC224Q55059903-7228BB54-BDA6-449A-9BBE-E081CB142677Q55430815-2744698A-E641-4D8C-80AA-878D90014DB4Q55450525-BE668CD9-A93B-4636-9891-9DE534E3BF79
P2860
Clinical significance of macroscopic T-wave alternans after sodium channel blocker administration in patients with Brugada syndrome.
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Clinical significance of macro ...... atients with Brugada syndrome.
@ast
Clinical significance of macro ...... atients with Brugada syndrome.
@en
type
label
Clinical significance of macro ...... atients with Brugada syndrome.
@ast
Clinical significance of macro ...... atients with Brugada syndrome.
@en
prefLabel
Clinical significance of macro ...... atients with Brugada syndrome.
@ast
Clinical significance of macro ...... atients with Brugada syndrome.
@en
P2093
P1476
Clinical significance of macro ...... atients with Brugada syndrome.
@en
P2093
Atsuyuki Watanabe
Daiji Miura
Hiroshi Morita
Kazufumi Nakamura
Kengo Fukushima Kusano
Kimikazu Banba
Nobuhiro Nishii
Satoshi Nagase
Takeshi Tada
P356
10.1111/J.1540-8167.2008.01346.X
P577
2007-10-04T00:00:00Z